[Adverse effects of atazanavir]
- PMID: 20116616
- DOI: 10.1016/S0213-005X(08)76619-9
[Adverse effects of atazanavir]
Abstract
Atazanavir is a drug that inhibits HIV protease. It has many of the characteristics of other protease inhibitors and also some advantages over these, such as the single dose of once per day, low capsule load, less gastrointestinal problems and a very friendly metabolic profile, including carbohydrate metabolism. Secondary high plasma bilirubin and jaundice are its main adverse effect which only on rare occasions requires stopping the drug. Other adverse effects, such as nephrolithiasis or ECG changes are extremely rare.
Similar articles
-
[Efficacy of atazanavir in simplification regimens].Enferm Infecc Microbiol Clin. 2008 Dec;26 Suppl 17:14-21. doi: 10.1016/S0213-005X(08)76615-1. Enferm Infecc Microbiol Clin. 2008. PMID: 20116612 Review. Spanish.
-
[Lipid profile of atazanavir].Enferm Infecc Microbiol Clin. 2008 Dec;26 Suppl 17:34-40. doi: 10.1016/S0213-005X(08)76618-7. Enferm Infecc Microbiol Clin. 2008. PMID: 20116615 Review. Spanish.
-
[Efficacy of atazanavir in rescue therapy].Enferm Infecc Microbiol Clin. 2008 Dec;26 Suppl 17:22-7. doi: 10.1016/S0213-005X(08)76616-3. Enferm Infecc Microbiol Clin. 2008. PMID: 20116613 Review. Spanish.
-
[Efficacy of atazanavir in treatment-naive patients].Enferm Infecc Microbiol Clin. 2008 Dec;26 Suppl 17:9-13. doi: 10.1016/S0213-005X(08)76614-X. Enferm Infecc Microbiol Clin. 2008. PMID: 20116611 Review. Spanish.
-
Atazanavir: new indication. First-line treatment: fewer gastrointestinal disorders but more cases of jaundice and a risk of torsades de pointes.Prescrire Int. 2009 Jun;18(101):104. Prescrire Int. 2009. PMID: 19637415
Cited by
-
Evaluation of adverse drug reactions in HIV positive patients in a tertiary care hospital.Perspect Clin Res. 2015 Jan-Mar;6(1):34-8. doi: 10.4103/2229-3485.148808. Perspect Clin Res. 2015. PMID: 25657900 Free PMC article.
-
High Prevalence of Severe Depression in Mexican Patients Diagnosed with HIV Treated with Efavirenz and Atazanavir: Clinical Follow-Up at Four Weeks and Analysis of TPH2 SNPs.J Clin Med. 2024 Dec 21;13(24):7823. doi: 10.3390/jcm13247823. J Clin Med. 2024. PMID: 39768746 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical